Home > Insider Trading > Filing (0000899243-19-026602)

Filing Details

Accession Number:: 0000899243-19-026602
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-11-04 17:58:31
Reporting Period:: 2019-11-04

Accepted Time:: 2019-11-04 17:58:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1720725	Oyster Point Pharma Inc.	OYST	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1456589	Versant Ventures Iv, Llc	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No
1456590	Versant Venture Capital Iv, L.p.	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No
1456591	Versant Side Fund Iv, L.p.	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No
1687880	Versant Venture Capital Vi, L.p.	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No
1765253	Versant Vantage I, L.p.	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No
1777651	Versant Vantage I Gp, L.p.	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No
1777652	Versant Ventures Vi Gp-Gp, Llc	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No
1777653	Versant Vantage I Gp-Gp, Llc	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No
1777654	Versant Ventures Vi Gp, L.p.	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	10,420	$0.00	12,438	No	4	C	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	1,654,359	$0.00	1,974,798	No	4	C	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	27,500	$16.00	2,002,298	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	1,941,500	$0.00	1,941,500	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	495,388	$0.00	2,436,888	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	125,000	$16.00	2,561,888	No	4	P	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	566,158	$0.00	566,158	No	4	C	Indirect	See footnote
Common Stock, Par Value $0.001 Per Share	Acquisiton	2019-11-04	437,500	$16.00	1,003,658	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnotes
No	4	C	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.001 Per Share	Series A Convertible Preferred Stock	Disposition	2019-11-04	10,420	$0.00	10,420	$0.00
Common Stock, Par Value $0.001 Per Share	Series A Convertible Preferred Stock	Disposition	2019-11-04	1,654,359	$0.00	1,654,359	$0.00
Common Stock, Par Value $0.001 Per Share	Series A Convertible Preferred Stock	Disposition	2019-11-04	1,941,500	$0.00	1,941,500	$0.00
Common Stock, Par Value $0.001 Per Share	Series B Convertible Preferred Stock	Disposition	2019-11-04	495,388	$0.00	495,388	$0.00
Common Stock, Par Value $0.001 Per Share	Series B Convertible Preferred Stock	Disposition	2019-11-04	566,158	$0.00	566,158	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Direct
No	4	C	Direct
No	4	C	Indirect

Footnotes

These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Common Stock ("Shares"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date.
Shares held by Versant Side Fund IV, L.P. ("Versant Side Fund IV").
Shares held by Versant Venture Capital IV, L.P. ("Versant IV").
Versant Ventures IV, LLC ("Versant Ventures IV") is the sole general partner of each of Versant IV and Versant Side Fund IV. Each of Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, Kirk G. Nielsen, Thomas F. Woiwode and Robin L. Praeger, as managing members of Versant Ventures IV, may be deemed to share voting and dispositive power over the shares held by Versant IV and Versant Side Fund IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports.
Shares directly held by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Each of Bradley J. Bolzon, Jerel C. Davis, Kirk G. Nielsen, Robin L. Praeger and Thomas F. Woiwode, and as November 1, 2019 Clare Ozawa, as managing members of Versant Ventures VI GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant VI; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein.
Shares held by Versant Vantage I, L.P. ("Versant Vantage"). Versant Vantage I GP, L.P. ("Versant Vantage I GP") is the general partner of Versant Vantage, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP. Each of Bradley J. Bolzon, Jerel C. Davis, Clare Ozawa, Robin L. Praeger and Thomas F. Woiwode, as managing members of Versant Vantage I GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant Vantage; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly, files separate Section 16 reports.